Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jasper Therapeutics (JSPR – Research Report) and ...

Millions of people across the world were unable to access Microsoft services, including their Outlook accounts, on Saturday.

Live webcasts of the presentations will be available on the News & Events – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

On Wednesday, RBC Capital adjusted its outlook on shares of Jasper Therapeutics (NASDAQ:JSPR), reducing the price target to $68 from the previous $70 while maintaining an... H.C. Wainwright has ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) announced additional positive Phase 1b/2a data on briquilimab as a conditioning agent in the treatment of Fanconi Anemia (FA).The data was ...